Skip to main
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 59%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare is well-positioned for growth with its strong financial performance, including solid revenue and earnings growth from its hospital operations and services segment, as well as its Conifer revenue cycle management solution. The company's balance sheet and cash flow are also healthy, with low leverage and strong operating cash flow and free cash flow. The company maintains its guidance for 2026 and shows confidence in future performance, with upside expected in the second quarter and potential for continued growth in its USPI and ASC businesses. There are risks to achieving target price, particularly related to changing healthcare policies and potential economic downturn, but overall, Tenet Healthcare shows strong potential for long-term value creation for investors.

Bears say

Tenet Healthcare is facing headwinds from the decrease in HIX enrollment and a negative sentiment toward hospitals and healthcare services. Despite strong financial performance, including increased revenue and cost flexing, the company's outlook remains cautious. Other risks to consider include potential regulatory changes and natural disasters in key regions.

Tenet Healthcare (THC) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 59% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 17 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $265.35, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $265.35, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.